Page last updated: 2024-11-08

nsc 88915

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate): a tyrosyl-DNA phosphodiesterase inhibitor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID259210
CHEMBL ID387152
SCHEMBL ID13856957
MeSH IDM0541826

Synonyms (21)

Synonym
nsc-88915
NSC88915 ,
NCI60_041972
21170-34-3
3,20-dioxopregn-4-en-21-yl 4-bromobenzenesulfonate
CHEMBL387152 ,
bdbm50158383
4-pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate)
2-((8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 4-bromobenzenesulfonate
[2-[(8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-bromobenzenesulfonate
SCHEMBL13856957
pregn-4-ene-3,20-dione, 21-[[(4-bromophenyl)sulfonyl]oxy]-
3,20-dioxopregn-4-en-21-yl 4-bromobenzenesulfonate; [2-[(8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-bromobenzenesulfonate
3,20-dioxopregn-4-en-21-yl 4-bromobenzene-1-sulfonate
DTXSID40943503
11-deoxycorticosterone, p-bromobenzenesulfonate
J6CZ92K8RU ,
pregn-4-ene-3,20-dione, 21-(((4-bromophenyl)sulfonyl)oxy)-
21-(((4-bromophenyl)sulfonyl)oxy)pregn-4-ene-3,20-dione
4-pregnen-21-ol-3,20-dione 21-(4-bromobenzenesulfonate)
unii-j6cz92k8ru
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bifunctional purine biosynthesis protein ATICHomo sapiens (human)IC50 (µMol)13.90000.01000.26000.7000AID282344
PH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)IC50 (µMol)11.00004.00004.00004.0000AID525943
Adenylate cyclase type 10Homo sapiens (human)IC50 (µMol)1.10001.10002.05003.0000AID366252
Tyrosyl-DNA phosphodiesterase 1Homo sapiens (human)IC50 (µMol)6.36600.01203.32138.4300AID1440488; AID456405; AID476073; AID673454; AID724054
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (60)

Processvia Protein(s)Taxonomy
microtubule cytoskeleton organizationRhodopsinBos taurus (cattle)
visual perceptionRhodopsinBos taurus (cattle)
phototransduction, visible lightRhodopsinBos taurus (cattle)
response to light stimulusRhodopsinBos taurus (cattle)
response to light intensityRhodopsinBos taurus (cattle)
gene expressionRhodopsinBos taurus (cattle)
absorption of visible lightRhodopsinBos taurus (cattle)
rhodopsin mediated signaling pathwayRhodopsinBos taurus (cattle)
thermotaxisRhodopsinBos taurus (cattle)
photoreceptor cell maintenanceRhodopsinBos taurus (cattle)
detection of temperature stimulus involved in thermoceptionRhodopsinBos taurus (cattle)
podosome assemblyRhodopsinBos taurus (cattle)
rod bipolar cell differentiationRhodopsinBos taurus (cattle)
brainstem developmentBifunctional purine biosynthesis protein ATICHomo sapiens (human)
nucleobase-containing compound metabolic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
GMP biosynthetic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
'de novo' IMP biosynthetic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
response to inorganic substanceBifunctional purine biosynthesis protein ATICHomo sapiens (human)
cerebellum developmentBifunctional purine biosynthesis protein ATICHomo sapiens (human)
cerebral cortex developmentBifunctional purine biosynthesis protein ATICHomo sapiens (human)
animal organ regenerationBifunctional purine biosynthesis protein ATICHomo sapiens (human)
'de novo' AMP biosynthetic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
dihydrofolate metabolic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
tetrahydrofolate biosynthetic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
'de novo' XMP biosynthetic processBifunctional purine biosynthesis protein ATICHomo sapiens (human)
cellular response to interleukin-7Bifunctional purine biosynthesis protein ATICHomo sapiens (human)
hippocampus developmentPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
signal transductionPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
protein dephosphorylationPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAdenylate cyclase type 10Homo sapiens (human)
epithelial cilium movement involved in extracellular fluid movementAdenylate cyclase type 10Homo sapiens (human)
glucose catabolic processAdenylate cyclase type 10Homo sapiens (human)
cAMP biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
spermatid developmentAdenylate cyclase type 10Homo sapiens (human)
positive regulation of cardiac muscle hypertrophyAdenylate cyclase type 10Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAdenylate cyclase type 10Homo sapiens (human)
negative regulation of mitochondrial membrane potentialAdenylate cyclase type 10Homo sapiens (human)
intracellular signal transductionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of axon extensionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of ossificationAdenylate cyclase type 10Homo sapiens (human)
positive regulation of glycogen catabolic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of mitochondrial depolarizationAdenylate cyclase type 10Homo sapiens (human)
regulation of membrane repolarizationAdenylate cyclase type 10Homo sapiens (human)
cellular response to inorganic substanceAdenylate cyclase type 10Homo sapiens (human)
neuron projection retractionAdenylate cyclase type 10Homo sapiens (human)
negative regulation of cardiac muscle cell contractionAdenylate cyclase type 10Homo sapiens (human)
regulation of mitophagyAdenylate cyclase type 10Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayAdenylate cyclase type 10Homo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of protein targeting to mitochondrionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processAdenylate cyclase type 10Homo sapiens (human)
neuron projection extensionAdenylate cyclase type 10Homo sapiens (human)
neuron projection maintenanceAdenylate cyclase type 10Homo sapiens (human)
mitochondrial ATP transmembrane transportAdenylate cyclase type 10Homo sapiens (human)
positive regulation of ATP biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
single strand break repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
DNA repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
double-strand break repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (26)

Processvia Protein(s)Taxonomy
G-protein alpha-subunit bindingRhodopsinBos taurus (cattle)
opsin bindingRhodopsinBos taurus (cattle)
guanyl-nucleotide exchange factor activityRhodopsinBos taurus (cattle)
11-cis retinal bindingRhodopsinBos taurus (cattle)
protein bindingRhodopsinBos taurus (cattle)
G protein-coupled photoreceptor activityRhodopsinBos taurus (cattle)
zinc ion bindingRhodopsinBos taurus (cattle)
identical protein bindingRhodopsinBos taurus (cattle)
arrestin family protein bindingRhodopsinBos taurus (cattle)
IMP cyclohydrolase activityBifunctional purine biosynthesis protein ATICHomo sapiens (human)
protein homodimerization activityBifunctional purine biosynthesis protein ATICHomo sapiens (human)
cadherin bindingBifunctional purine biosynthesis protein ATICHomo sapiens (human)
phosphoribosylaminoimidazolecarboxamide formyltransferase activityBifunctional purine biosynthesis protein ATICHomo sapiens (human)
protein bindingPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
myosin phosphatase activityPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
metal ion bindingPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
protein serine/threonine phosphatase activityPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
magnesium ion bindingAdenylate cyclase type 10Homo sapiens (human)
adenylate cyclase activityAdenylate cyclase type 10Homo sapiens (human)
ATP bindingAdenylate cyclase type 10Homo sapiens (human)
manganese ion bindingAdenylate cyclase type 10Homo sapiens (human)
ATPase bindingAdenylate cyclase type 10Homo sapiens (human)
bicarbonate bindingAdenylate cyclase type 10Homo sapiens (human)
double-stranded DNA bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
single-stranded DNA bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
exonuclease activityTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
protein bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
3'-tyrosyl-DNA phosphodiesterase activityTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
Golgi membraneRhodopsinBos taurus (cattle)
photoreceptor disc membraneRhodopsinBos taurus (cattle)
plasma membraneRhodopsinBos taurus (cattle)
cell-cell junctionRhodopsinBos taurus (cattle)
membraneRhodopsinBos taurus (cattle)
outer membraneRhodopsinBos taurus (cattle)
photoreceptor outer segment membraneRhodopsinBos taurus (cattle)
photoreceptor inner segment membraneRhodopsinBos taurus (cattle)
sperm midpieceRhodopsinBos taurus (cattle)
rod photoreceptor outer segmentRhodopsinBos taurus (cattle)
sperm head plasma membraneRhodopsinBos taurus (cattle)
G protein-coupled receptor complexRhodopsinBos taurus (cattle)
cytosolBifunctional purine biosynthesis protein ATICHomo sapiens (human)
plasma membraneBifunctional purine biosynthesis protein ATICHomo sapiens (human)
membraneBifunctional purine biosynthesis protein ATICHomo sapiens (human)
extracellular exosomeBifunctional purine biosynthesis protein ATICHomo sapiens (human)
cytosolBifunctional purine biosynthesis protein ATICHomo sapiens (human)
photoreceptor inner segmentPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
nucleoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytosolPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
photoreceptor outer segment membranePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
intercellular bridgePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
mitotic spindlePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
microtubule cytoskeletonAdenylate cyclase type 10Homo sapiens (human)
motile ciliumAdenylate cyclase type 10Homo sapiens (human)
extracellular regionAdenylate cyclase type 10Homo sapiens (human)
nucleusAdenylate cyclase type 10Homo sapiens (human)
mitochondrionAdenylate cyclase type 10Homo sapiens (human)
cytosolAdenylate cyclase type 10Homo sapiens (human)
apical plasma membraneAdenylate cyclase type 10Homo sapiens (human)
dendriteAdenylate cyclase type 10Homo sapiens (human)
neuronal cell bodyAdenylate cyclase type 10Homo sapiens (human)
basal part of cellAdenylate cyclase type 10Homo sapiens (human)
perinuclear region of cytoplasmAdenylate cyclase type 10Homo sapiens (human)
central region of growth coneAdenylate cyclase type 10Homo sapiens (human)
astrocyte end-footAdenylate cyclase type 10Homo sapiens (human)
cytoplasmAdenylate cyclase type 10Homo sapiens (human)
nucleoplasmTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
cytoplasmTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
plasma membraneTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
intracellular membrane-bounded organelleTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
nucleusTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID365155Inhibition of bovine retinal rod outer-segment photoactivated rhodopsin-transducer interaction by transducer release assay2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
AID476075Inhibition of human Tdp1 expressed in Escherichia coli assessed as blockade of enzyme-mediated hydrolysis of phosphodiester linkage between tyrosine and double stranded DNA substrate bearing 5^-overhang end by SDS-PAGE electrophoresis2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID366252Inhibition of human recombinant soluble adenylyl cyclase2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID476076Binding affinity to human Tdp1 amine-coupled to sensor chip assessed as increase in resonance units by SPR2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID476078Inhibition of human Tdp1 H493R mutant assessed as decrease in enzyme-DNA complexes by SDS-PAGE2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID282344Inhibition of human AICAR Tfase2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
AID673454Inhibition of human recombinant Tdp1 using 5'-[32P]-labeled single-stranded DNA oligonucleotide containing 3'-phosphotyrosine as substrate assessed as prevention of generation of oligonucleotide with free 3'-phosphate after 15 mins by PAGE analysis2012Journal of medicinal chemistry, 05-10, Volume: 55, Issue:9
Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
AID365154Binding affinity to photoactivated rhodopsin in bovine retinal rod outer-segment membranes assessed as induction of extra receptor MII state stabilization by UV/visible difference spectroscopy2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
AID525943Inhibition of PHLPP2 phosphatase domain expressed in Escherichia coli2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID366254Inhibition of forskolin-stimulated adenylyl cyclase 1 activity expressed in HEK293 cells at 100 uM2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID525944Inhibition of PHLPP in human HT20 cells assessed as increase of phosphorylation of Akt on Ser 473 at 100 to 250 uM after 24 hrs by immunoblotting relative to control2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID366256Inhibition of forskolin-stimulated adenylyl cyclase 5 activity expressed in HEK293 cells at 100 uM2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID476077Inhibition of human Tdp1 H493R mutant assessed as decrease in enzyme-DNA complexes by DNA sequencing method2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID366255Inhibition of basal activity of adenylyl cyclase 2 expressed in HEK293 cells at 100 uM2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID366251Inhibition of Spirulina platensis adenylyl cyclase assessed as cAMP level by cAMP immunogenic assay2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID366257Inhibition of basal activity of adenylyl cyclase 9 expressed in HEK293 cells at 100 uM2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID724054Inhibition of recombinant Tdp1 (unknown origin) using 5'-[32P]-labeled single-stranded DNA oligonucleotide containing 3'-phosphotyrosine as substrate after 15 mins by PAGE analysis2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).
AID476072Inhibition of human APE1 up to 100 uM2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID456405Inhibition of human tyrosyl-DNA phosphodiesterase 1 after 30 mins by alpha high throughput screening assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.
AID476074Inhibition of human Tdp1 expressed in Escherichia coli assessed as blockade of enzyme-mediated hydrolysis of phosphodiester linkage between tyrosine and double stranded DNA substrate bearing blunt end by SDS-PAGE electrophoresis2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID476073Inhibition of human Tdp1 expressed in Escherichia coli assessed as blockade of enzyme-mediated hydrolysis of phosphodiester linkage between tyrosine and 3^-end of single stranded N14Y DNA substrate by SDS-PAGE electrophoresis2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID366253Inhibition of forskolin-stimulated human transmembrane adenylyl cyclase activity in HEK293 cells at 100 uM2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID1440488Inhibition of His-tagged full length human Tdp12017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Type I DNA Topoisomerases.
AID476071Inhibition of human DNA topoisomerase 1 up to 100 uM2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]